The risk stage of subclinical inflammation is not comparable to the stage of clinical arthritis. Response to 'Comments and perspectives on the TREAT EARLIER study'

Quirine A. Dumoulin; Annette H.M. Van Der Helm-Van Mil

doi:10.55563/clinexprheumatol/7454k1

The risk stage of subclinical inflammation is not comparable to the stage of clinical arthritis. Response to 'Comments and perspectives on the TREAT EARLIER study'

Quirine A. Dumoulin
, Annette H.M. Van Der Helm-Van Mil

Rheumatology

Leiden University

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	S-8
Number of pages	1
Journal	Clinical and Experimental Rheumatology
Volume	43
Issue number	11
DOIs	https://doi.org/10.55563/clinexprheumatol/7454k1
Publication status	Published - 1 Dec 2025

Access to Document

10.55563/clinexprheumatol/7454k1

Cite this

@article{38350d681457415482db33e96f04ad79,

title = "The risk stage of subclinical inflammation is not comparable to the stage of clinical arthritis. Response to 'Comments and perspectives on the TREAT EARLIER study'",

author = "Dumoulin, \{Quirine A.\} and \{Van Der Helm-Van Mil\}, \{Annette H.M.\}",

year = "2025",

month = dec,

day = "1",

doi = "10.55563/clinexprheumatol/7454k1",

language = "English",

volume = "43",

pages = "S--8",

journal = "Clinical and Experimental Rheumatology",

issn = "0392-856X",

publisher = "Clinical and Experimental Rheumatology S.A.S.",

number = "11",

}

The risk stage of subclinical inflammation is not comparable to the stage of clinical arthritis. Response to 'Comments and perspectives on the TREAT EARLIER study'. / Dumoulin, Quirine A.; Van Der Helm-Van Mil, Annette H.M.
In: Clinical and Experimental Rheumatology, Vol. 43, No. 11, 01.12.2025, p. S-8.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - The risk stage of subclinical inflammation is not comparable to the stage of clinical arthritis. Response to 'Comments and perspectives on the TREAT EARLIER study'

AU - Dumoulin, Quirine A.

AU - Van Der Helm-Van Mil, Annette H.M.

PY - 2025/12/1

Y1 - 2025/12/1

UR - https://www.scopus.com/pages/publications/105024730329

U2 - 10.55563/clinexprheumatol/7454k1

DO - 10.55563/clinexprheumatol/7454k1

M3 - Comment/Letter to the editor

C2 - 40658493

AN - SCOPUS:105024730329

SN - 0392-856X

VL - 43

SP - S-8

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

IS - 11

ER -

The risk stage of subclinical inflammation is not comparable to the stage of clinical arthritis. Response to 'Comments and perspectives on the TREAT EARLIER study'

Access to Document

Other files and links

Embargoed Document

Cite this